Lars Neumann News Today

Surgery and chemotherapy significantly improved both overall survival (OS) and cancer-specific survival (CSS) in patients with liver metastases originating from ovarian cancer (OC), who generally face a poor prognosis with a 5-year survival rate of less than 30%.

Monitoring metal ion concentrations and chelation therapy is hypothesized to alleviate symptoms and diseases caused by neuroinflammation.

Does your blood type play a role in your risk for disease? Find out how it fares in the face of certain conditions.

Results from the OPEB-01/APGOT-OV4 trial highlight the potential benefits of using olaparib, pembrolizumab, and bevacizumab as a triplet maintenance therapy for patients who have responded to chemotherapy after experiencing platinum-sensitive recurrence in ovarian cancer.

The addition of PARP inhibitors for the treatment of patients with BRCA-mutated advanced ovarian cancer has provided clinicians with a stronger set of treatment options. Looking at how the BRCA mutation responds to these inhibitors is then vital to deciding the patient’s treatment path.

Potassium keeps all of your cells working right. Learn which foods offer an abundant supply of this essential nutrient.

Results from ATLANTE/ENGOT-ov29 show that atezolizumab did not significantly improve progression-free survival (PFS) compared with placebo plus bevacizumab for patients with platinum-sensitive ovarian cancer.

The brain doesn’t always stay the same. Mental disorders, health issues, and lifestyle habits can alter the way it looks and works.

Sometimes a cough is just a cough. But if it sticks around for a while, you may have something more serious. Find out more about what may be causing your nagging cough.

Under Health Ministry censure, hospital faces demand for damages; lawyer for unnamed pair says they won't tell anyone, not even their kids, that the dad isn't their genetic parent